HIT Director Timothy Hayes reports 28,159 share disposition, 5,730 grant
Rhea-AI Filing Summary
Insider transactions by Director Timothy Hayes at Health In Tech, Inc. (HIT)
Director Timothy Hayes reported a disposition and a later acquisition of Class A common stock. On 10/03/2025 he disposed of 28,159 restricted shares that were forfeitable pro rata at the issuer's annual meeting, leaving 100,315 shares beneficially owned. On 10/08/2025 he acquired 5,730 restricted shares at a purchase price of $3.49 per share; those newly granted restricted shares vest quarterly from the grant date subject to continued service. The filing shows Hayes remains a significant insider and that his post-transaction holdings total 106,045 shares, combining previously owned and newly granted restricted stock.
Positive
- Continued insider alignment: reporting person retains 106,045 shares after transactions, signaling material ongoing ownership
- Retention-focused compensation: 5,730 restricted shares vest quarterly, tying pay to ongoing service
Negative
- Forfeiture-related disposition: 28,159 restricted shares were disposed due to forfeiture rules at the annual meeting, temporarily reducing contingent holdings
- Potential near-term dilution: new restricted grants increase outstanding beneficial holdings to 106,045
Insights
Director executed a planned disposal tied to forfeiture rules and received new restricted grants that vest over time.
The disposition of 28,159 restricted shares on 10/03/2025 was tied to forfeiture provisions that lapsed at the company's annual meeting, which reduced contingent holdings rather than an outright open-market sale. The later grant of 5,730 restricted shares on 10/08/2025 at $3.49 vests quarterly and requires continuous service, aligning compensation with retention goals.
Governance risks include concentration of insider ownership and timing of grants around corporate events; monitor vesting schedule and any future open-market trades over the next 12 months to assess dilution and insider alignment with shareholders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 5,730 | $3.49 | $20K |
| Disposition | Class A Common Stock | 28,159 | $0.00 | -- |
Footnotes (1)
- Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date. Includes 5,730 shares of restricted stock and 100,315 shares of Class A Common Stock.
